Vimarsana
Biggest News Aggregation in the World

Page 4 - Life Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Technologies Today - Breaking & Trending Today

Armonica Announces Appointment of Emily Milsovic as CEO - Vimarsana News

Armonica Announces Appointment of Emily Milsovic as CEO

/PRNewswire/ -- Armonica, a pioneer in optical epigenetic sequencing has appointed Emily Milsovic as its new chief executive officer (CEO), effective...

Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer - Vimarsana News

Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer

/PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong,...

Araceli Biosciences Introduces Matt Beaudet as New President and Chief ... - Vimarsana News

Araceli Biosciences Introduces Matt Beaudet as New President and Chief ...

Araceli Biosciences Introduces Matt Beaudet as New President and Chief ...

Antisense oligonucleotide therapeutic approach for Timothy syndrome - Vimarsana News

Antisense oligonucleotide therapeutic approach for Timothy syndrome

Timothy syndrome (TS) is a severe, multisystem disorder characterized by autism, epilepsy, long-QT syndrome and other neuropsychiatric conditions1. TS type 1 (TS1) is caused by a gain-of-function variant in the alternatively spliced and developmentally enriched CACNA1C exon 8A, as opposed to its counterpart exon 8. We previously uncovered several phenotypes in neurons derived from patients with TS1, including delayed channel inactivation, prolonged depolarization-induced calcium rise, impaired interneuron migration, activity-dependent dendrite retraction and an unanticipated ...

Source: nature.com
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer - Vimarsana News

Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer

/PRNewswire/ -- Congruence Therapeutics, a leading computationally-driven biotechnology company developing a pipeline of novel small molecules for diseases...